Marc B. Garnick, M.D.
Clinical Professor, Department of Medicine, Harvard Medical School
Professor, Medicine, Beth Israel Deaconess Medical Center
Contact Info
Marc Garnick
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Mailstop: HIM 1049
Phone: 617-667-9187
Fax: 617-731-1908
mgarnick@bidmc.harvard.edu
Administrative Assistant
Medicine
Beth Israel Deaconess Medical Center
Phone: 617-667-5288
sdowling@caregroup.harvard.edu
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Mailstop: HIM 1049
Phone: 617-667-9187
Fax: 617-731-1908
mgarnick@bidmc.harvard.edu
Assistant
Sylvia DowlingAdministrative Assistant
Medicine
Beth Israel Deaconess Medical Center
Phone: 617-667-5288
sdowling@caregroup.harvard.edu
DF/HCC Program Affiliation
Prostate CancerResearch Abstract
Dr. Garnick's predominant interest is urologic cancer, with a specialization in clinical investigation related to prostate cancer. Dr. Garnick is co-director of the Barry Hershey Foundation. In addition to his academic affiliation with Harvard Medical School and the Beth Israel Deaconess Medical Center, he is Chief Medical Officer and the Executive Vice President of PRAECIS Pharmaceuticals, Inc. where he is involved with the clinical development of a novel and potent GnRH antagonist, Abarelix.Publications
- Garnick MB, Fair WR.Combating prostate cancer.Sci Am 1998 Dec;279(6):74-83.
9828467
